The global recombinant proteins market was valued at $2.5 billion in 2023, and is projected to reach $5.2 billion by 2033, growing at a CAGR of 7.7% from 2024 to 2033.
Report Code : A11233 | Pages : 405 | Category : Life Sciences
The global human recombinant insulin market was valued at $27.6 billion in 2023, and is projected to reach $34.7 billion by 2033, growing at a CAGR of 2.4% from 2024 to 2033.
Report Code : A281792 | Pages : 300 | Category : Life Sciences
The Australia vaccines market was valued at $0.6 billion in 2023, and is projected to reach $1.2 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.
Report Code : A325353 | Pages : 90 | Category : Life Sciences
The global vaccine technologies market was valued at $48.5 billion in 2023, and is projected to reach $90.6 billion by 2033, growing at a CAGR of 6.4% from 2024 to 2033.
Report Code : A172299 | Pages : 348 | Category : Life Sciences
The global newcastle disease vaccine market was valued at $0.4 billion in 2023, and is projected to reach $0.6 billion by 2033, growing at a CAGR of 4.4% from 2024 to 2033.
Report Code : A324484 | Pages : 216 | Category : Life Sciences
